Related Experiment Video
Updated: Oct 11, 2025
06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
35.4K
Reduction in Copper Uptake and Inhibition of Prostate Cancer Cell Proliferation by Novel Steroid-based Compounds
Fang Xie1, Fangyu Peng2,3,4
1Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, U.S.A.
Anticancer Research
|December 1, 2021
Summary
New steroid compounds effectively reduced copper uptake and suppressed prostate cancer cell proliferation. These findings suggest potential for steroid-based inhibitors in targeted anti-copper therapy for prostate cancer.
Area of Science:
- Oncology
- Biochemistry
- Medicinal Chemistry
Background:
- Human copper transporter 1 (hCT1) knockdown reduces copper uptake and inhibits prostate cancer growth.
- Steroid-based compounds have shown potential as hCT1 inhibitors.
Purpose of the Study:
- Evaluate the effects of novel steroid-based compounds on copper uptake and prostate cancer cell proliferation.
- Identify potent steroid-based hCT1 inhibitors for anticancer applications.
Main Methods:
- Synthesis of novel steroid-based compounds.
- 64Cu uptake and copper quantification assays (ICP-MS) to measure cellular copper uptake.
- CCK-8 assay to assess prostate cancer cell proliferation.
Main Results:
- Synthesized steroid-based compounds significantly reduced copper uptake in prostate cancer cells.
- Compound 6 demonstrated the strongest copper uptake inhibition and suppressed cell proliferation.
Conclusions:
- Steroid-based compounds can effectively reduce copper uptake and inhibit prostate cancer cell proliferation.
- These compounds show promise as novel anticancer agents for targeted anti-copper therapy in prostate cancer and other hypermetabolic cancers.
